The Role of Artificial Hearts and Mechanical Circulatory Support

Artificial hearts and mechanical circulatory support (MCS) devices play a crucial role in treating patients with end-stage heart failure who are awaiting a heart transplant or are ineligible for one. These advanced technologies help maintain blood circulation and improve survival rates in critically ill patients. A total artificial heart (TAH) is a device that completely replaces the heart, taking over both pumping functions of the ventricles. It is used for patients with severe biventricular failure who cannot survive with traditional therapies. Modern TAHs, such as the SynCardia Total Artificial Heart, provide a temporary or long-term solution for patients waiting for a transplant. More commonly, ventricular assist devices (VADs) support the failing heart by assisting either the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD). LVADs, such as the HeartMate 3, help pump blood from the left ventricle to the aorta, relieving strain on the heart. These devices can be a bridge to transplant (BTT) or a destination therapy (DT) for patients who are not eligible for transplantation. Although artificial hearts and VADs improve survival and quality of life, complications like blood clots, infections, and device malfunctions require careful monitoring. Advances in technology continue to enhance their safety and effectiveness, offering new hope for heart failure patients.

    Related Conference of The Role of Artificial Hearts and Mechanical Circulatory Support

    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    37th Annual Cardiologists Conference

    London, UK
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    March 23-24, 2026

    13th International Conference on Hypertension and Cardiovascular Diseases

    London, UK
    March 26-27, 2026

    13th International Conference on Interventional Cardiology

    London,
    April 06-07, 2026

    40th World Congress on Heart Diseases

    Paris, France
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    April 15-16, 2026

    8th World Heart Congress

    Tokyo, Japan
    April 29-30, 2026

    6th World Congress on Congestive Heart Failure & Angina

    Paris, France
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    13th World Congress on Hypertension, Cardiology, Primary Health and Patient Care

    Paris, France
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    June 15-16, 2026

    7th International Conference on Cardiac Imaging and Diagnostics

    Paris, France
    June 15-16, 2026

    7th European Summit on Cardiology Research

    Zurich, Switzerland
    July 23-24, 2026

    13th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

    Paris, France
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France
    August 17-18, 2026

    4th International Conference on World Heart Care

    Toronto, Canada
    August 24-25, 2026

    15th World Heart Congress

    London, UK
    August 27-28, 2026

    40th European Cardiology Conference

    Berlin, Germany
    November 09-10, 2026

    9th Global Cardiovascular Research and Clinical Cardiology

    Paris, France
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France

    The Role of Artificial Hearts and Mechanical Circulatory Support Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in